Department of Structural Biology, Stanford University, Stanford, California, USA.
J Clin Invest. 2010 Nov;120(11):3801-4. doi: 10.1172/JCI44559. Epub 2010 Oct 25.
During embryo implantation and initiation of pregnancy, uterine NK (uNK) cells engage invasive fetal trophoblasts to remodel vessels that conduct blood to the placenta. This partnership, involving uNK cell receptors that recognize HLA-C ligands on trophoblasts, varies the course of human pregnancy because the genes for both receptors and ligands are extraordinarily diverse. Several pregnancy disorders are attributed to insufficient trophoblast invasion and the limitation it imposes on human reproduction. Previously, a particular combination of fetal HLA-C and maternal inhibitory uNK cell receptor was associated with predisposition for preeclampsia. In this issue of the JCI, Hiby and colleagues extend this correlation to recurrent miscarriage and fetal growth restriction, revealing the common mechanism underlying these common pregnancy syndromes. Equally important, they show that mothers with an activating receptor of similar specificity to the inhibitory receptor are less likely to suffer disordered pregnancy.
在胚胎植入和妊娠开始时,子宫自然杀伤 (uNK) 细胞与侵袭性胎儿滋养层细胞相互作用,重塑向胎盘输送血液的血管。这种涉及 uNK 细胞受体识别滋养层细胞 HLA-C 配体的伙伴关系,改变了人类妊娠的进程,因为受体和配体的基因都非常多样化。几种妊娠疾病归因于滋养层细胞侵袭不足及其对人类生殖的限制。此前,胎儿 HLA-C 和母体抑制性 uNK 细胞受体的特定组合与子痫前期易感性有关。在本期 JCI 中,Hiby 及其同事将这种相关性扩展到复发性流产和胎儿生长受限,揭示了这些常见妊娠综合征的共同机制。同样重要的是,他们表明,具有与抑制性受体相似特异性的激活受体的母亲不太可能遭受紊乱的妊娠。